Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational TrialJohn M.S. Bartlett, Daniel Rea, Margaret Grant et al.|Journal of Clinical Oncology|2011Cited by 199
Heterogeneous<i>HER2</i>Gene AmplificationAlastair I. Bartlett, John M.S. Bartlett, Jane Starcyznski et al.|American Journal of Clinical Pathology|2011Cited by 106
Automated image analysis for high‐throughput quantitative detection of ER and PR expression levels in large‐scale clinical studies: The TEAM Trial ExperienceDana Faratian, John M.S. Bartlett, Dan Rea et al.|Histopathology|2009Cited by 57